Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYFrontiers in Nutrition

Association between the prognostic nutritional index and cognitive impairment in patients with heart failure: a cross-sectional study

4 affiliations
  1. 1School of Nursing, Fujian Medical University, Fuzhou, Fujian, China
  2. 2Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
  3. 3Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
  4. 4Fujian Provincial Special Reserve Talents Laboratory, Fuzhou, Fujian, China

Abstract

BackgroundThe prognostic nutritional index (PNI), calculated from serum albumin and peripheral lymphocyte count, is commonly interpreted as a nutritional–inflammatory marker. This study investigated the association between the PNI and cognitive impairment (CI) among patients with heart failure (HF).MethodsThis cross-sectional study included 153 patients with HF. Before cognitive status classification and statistical analysis, one point was added to the original Montreal Cognitive Assessment (MoCA) total score for participants with fewer than 12 years of education. Participants were classified into the CI group (education-corrected MoCA <26) or the non-CI group (education-corrected MoCA ≥26).ResultsCI was identified in 93 patients (60.8%). The median PNI was lower in the CI group than in the non-CI group [44.10 (40.55–47.00) vs. 47.08 (44.62–50.28), p < 0.001]. After adjusting for age, sex, and educational attainment, each five-point increase in the PNI was associated with lower odds of prevalent CI (odds ratio (OR): 0.562, 95% confidence interval (95% CI): 0.348–0.910; p = 0.019). The base clinical model had an area under the curve (AUC) of 0.868, and the PNI-extended model had an AUC of 0.882; the increment was small and non-significant (ΔAUC: 0.014, 95% CI: −0.008 to 0.036; DeLong p = 0.204). In a sensitivity analysis, albumin was independently associated with CI (OR: 0.362 per 5-g/L increase, 95% CI: 0.172–0.759; p = 0.007), and the PNI-extended model did not outperform the albumin-extended model (AUC: 0.882 vs. 0.887; ΔAUC: −0.005, 95% CI: −0.022 to 0.013; DeLong p = 0.588).ConclusionLower PNI was independently associated with higher odds of prevalent CI in patients with HF. However, its incremental discrimination beyond age, sex, and educational attainment was small and statistically non-significant, and the PNI-extended model did not outperform the albumin-extended model in the sensitivity analysis. These findings support an association but do not establish incremental clinical utility; the decision-curve analysis is exploratory, and external validation is required.

Related

  1. Nutritional Exposures and Cognitive Impairment in Alcohol Use Disorder: A Structured Narrative Review of Prioritized Human Evidence
    Gabriela Elena Strete, Alexandru Mischie, Lorena Mihaela Grebenisan +8
    NutrientsPeer-reviewedCC BY 4.0NeurologyCrossref
  2. Dietary Patterns and Nutritional Interventions for Cognitive Impairment in Parkinson’s Disease: A Critical Narrative Review
    Amaal Aldakheel, Najeeb Qadi
    NutrientsPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  3. Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
    Rachel F. Buckley, Diana L Townsend, Colin Birkenbihl +97
    JAMAPeer-reviewedLicence not statedFull text16 citedPsychiatry & mental healthOpenAlex
  4. Plasma p-tau181 moderates the association between ten-year atherosclerotic cardiovascular disease risk and mild cognitive impairment – HABS-HD
    Joey A. Contreras, Nancy E. Ortega, Raymond Jones +2
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Association of conventional and non-conventional lipid profile with cognitive impairment among type 2 diabetic patients
    Behnaz Esmaeili, Elahe Hesari, Kazem Khalaji +6
    Journal of Diabetes and Metabolic DisordersPeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
BibTeX
@article{li2026association,
  title = {{Association between the prognostic nutritional index and cognitive impairment in patients with heart failure: a cross-sectional study}},
  author = {Chengyang Li and Yingxuan Gao and Qi Niu and Liangwan Chen and Liangwan Chen and Yanjuan Lin and Yanjuan Lin},
  journal = {Frontiers in Nutrition},
  year = {2026},
  month = oct,
  doi = {10.3389/fnut.2026.1939333},
  url = {https://doi.org/10.3389/fnut.2026.1939333},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Association between the prognostic nutritional index and cognitive impairment in patients with heart failure: a cross-sectional study
AU  - Chengyang Li
AU  - Yingxuan Gao
AU  - Qi Niu
AU  - Liangwan Chen
AU  - Liangwan Chen
AU  - Yanjuan Lin
AU  - Yanjuan Lin
PY  - 2026
DA  - 2026/10/26
JO  - Frontiers in Nutrition
DO  - 10.3389/fnut.2026.1939333
UR  - https://doi.org/10.3389/fnut.2026.1939333
AB  - BackgroundThe prognostic nutritional index (PNI), calculated from serum albumin and peripheral lymphocyte count, is commonly interpreted as a nutritional–inflammatory marker. This study investigated the association between the PNI and cognitive impairment (CI) among patients with heart failure (HF).MethodsThis cross-sectional study included 153 patients with HF. Before cognitive status classification and statistical analysis, one point was added to the original Montreal Cognitive Assessment (MoCA) total score for participants with fewer than 12 years of education. Participants were classified into the CI group (education-corrected MoCA <26) or the non-CI group (education-corrected MoCA ≥26).ResultsCI was identified in 93 patients (60.8%). The median PNI was lower in the CI group than in the non-CI group [44.10 (40.55–47.00) vs. 47.08 (44.62–50.28), p < 0.001]. After adjusting for age, sex, and educational attainment, each five-point increase in the PNI was associated with lower odds of prevalent CI (odds ratio (OR): 0.562, 95% confidence interval (95% CI): 0.348–0.910; p = 0.019). The base clinical model had an area under the curve (AUC) of 0.868, and the PNI-extended model had an AUC of 0.882; the increment was small and non-significant (ΔAUC: 0.014, 95% CI: −0.008 to 0.036; DeLong p = 0.204). In a sensitivity analysis, albumin was independently associated with CI (OR: 0.362 per 5-g/L increase, 95% CI: 0.172–0.759; p = 0.007), and the PNI-extended model did not outperform the albumin-extended model (AUC: 0.882 vs. 0.887; ΔAUC: −0.005, 95% CI: −0.022 to 0.013; DeLong p = 0.588).ConclusionLower PNI was independently associated with higher odds of prevalent CI in patients with HF. However, its incremental discrimination beyond age, sex, and educational attainment was small and statistically non-significant, and the PNI-extended model did not outperform the albumin-extended model in the sensitivity analysis. These findings support an association but do not establish incremental clinical utility; the decision-curve analysis is exploratory, and external validation is required.
SN  - 2296-861X
ER  -